Cargando…

Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T

INTRODUCTION: Magnetic resonance spectroscopic imaging (MRSI) has the potential to add a layer of understanding of the neurobiological mechanisms underlying brain diseases, disease progression, and treatment efficacy. Limitations related to metabolite fitting of low signal‐to‐noise ratios data, sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhogal, Alex A., Broeders, Tommy A. A., Morsinkhof, Lisan, Edens, Mirte, Nassirpour, Sahar, Chang, Paul, Klomp, Dennis W. J., Vinkers, Christiaan H., Wijnen, Jannie P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749561/
https://www.ncbi.nlm.nih.gov/pubmed/33216472
http://dx.doi.org/10.1002/brb3.1852
_version_ 1783625328512466944
author Bhogal, Alex A.
Broeders, Tommy A. A.
Morsinkhof, Lisan
Edens, Mirte
Nassirpour, Sahar
Chang, Paul
Klomp, Dennis W. J.
Vinkers, Christiaan H.
Wijnen, Jannie P.
author_facet Bhogal, Alex A.
Broeders, Tommy A. A.
Morsinkhof, Lisan
Edens, Mirte
Nassirpour, Sahar
Chang, Paul
Klomp, Dennis W. J.
Vinkers, Christiaan H.
Wijnen, Jannie P.
author_sort Bhogal, Alex A.
collection PubMed
description INTRODUCTION: Magnetic resonance spectroscopic imaging (MRSI) has the potential to add a layer of understanding of the neurobiological mechanisms underlying brain diseases, disease progression, and treatment efficacy. Limitations related to metabolite fitting of low signal‐to‐noise ratios data, signal variations due to partial‐volume effects, acquisition and extracranial lipid artifacts, along with clinically relevant aspects such as scan time constraints, are among the challenges associated with in vivo MRSI. METHODS: The aim of this work was to address some of these factors and to develop an acquisition, reconstruction, and postprocessing pipeline to derive lipid‐suppressed metabolite values of central brain structures based on free‐induction decay measurements made using a 7 T MR scanner. Anatomical images were used to perform high‐resolution (1 mm(3)) partial‐volume correction to account for gray matter, white matter (WM), and cerebral‐spinal fluid signal contributions. Implementation of automatic quality control thresholds and normalization of metabolic maps from 23 subjects to the Montreal Neurological Institute (MNI) standard atlas facilitated the creation of high‐resolution average metabolite maps of several clinically relevant metabolites in central brain regions, while accounting for macromolecular distributions. Partial‐volume correction improved the delineation of deep brain nuclei. We report average metabolite values including glutamate + glutamine (Glx), glycerophosphocholine, choline and phosphocholine (tCho), (phospo)creatine, myo‐inositol and glycine (mI‐Gly), glutathione, N‐acetyl‐aspartyl glutamate(and glutamine), and N‐acetyl‐aspartate in the basal ganglia, central WM (thalamic radiation, corpus callosum) as well as insular cortex and intracalcarine sulcus. CONCLUSION: MNI‐registered average metabolite maps facilitate group‐based analysis, thus offering the possibility to mitigate uncertainty in variable MRSI data.
format Online
Article
Text
id pubmed-7749561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77495612020-12-23 Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T Bhogal, Alex A. Broeders, Tommy A. A. Morsinkhof, Lisan Edens, Mirte Nassirpour, Sahar Chang, Paul Klomp, Dennis W. J. Vinkers, Christiaan H. Wijnen, Jannie P. Brain Behav Original Research INTRODUCTION: Magnetic resonance spectroscopic imaging (MRSI) has the potential to add a layer of understanding of the neurobiological mechanisms underlying brain diseases, disease progression, and treatment efficacy. Limitations related to metabolite fitting of low signal‐to‐noise ratios data, signal variations due to partial‐volume effects, acquisition and extracranial lipid artifacts, along with clinically relevant aspects such as scan time constraints, are among the challenges associated with in vivo MRSI. METHODS: The aim of this work was to address some of these factors and to develop an acquisition, reconstruction, and postprocessing pipeline to derive lipid‐suppressed metabolite values of central brain structures based on free‐induction decay measurements made using a 7 T MR scanner. Anatomical images were used to perform high‐resolution (1 mm(3)) partial‐volume correction to account for gray matter, white matter (WM), and cerebral‐spinal fluid signal contributions. Implementation of automatic quality control thresholds and normalization of metabolic maps from 23 subjects to the Montreal Neurological Institute (MNI) standard atlas facilitated the creation of high‐resolution average metabolite maps of several clinically relevant metabolites in central brain regions, while accounting for macromolecular distributions. Partial‐volume correction improved the delineation of deep brain nuclei. We report average metabolite values including glutamate + glutamine (Glx), glycerophosphocholine, choline and phosphocholine (tCho), (phospo)creatine, myo‐inositol and glycine (mI‐Gly), glutathione, N‐acetyl‐aspartyl glutamate(and glutamine), and N‐acetyl‐aspartate in the basal ganglia, central WM (thalamic radiation, corpus callosum) as well as insular cortex and intracalcarine sulcus. CONCLUSION: MNI‐registered average metabolite maps facilitate group‐based analysis, thus offering the possibility to mitigate uncertainty in variable MRSI data. John Wiley and Sons Inc. 2020-11-20 /pmc/articles/PMC7749561/ /pubmed/33216472 http://dx.doi.org/10.1002/brb3.1852 Text en © 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Bhogal, Alex A.
Broeders, Tommy A. A.
Morsinkhof, Lisan
Edens, Mirte
Nassirpour, Sahar
Chang, Paul
Klomp, Dennis W. J.
Vinkers, Christiaan H.
Wijnen, Jannie P.
Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title_full Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title_fullStr Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title_full_unstemmed Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title_short Lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2D (1)H magnetic resonance spectroscopic imaging at 7 T
title_sort lipid‐suppressed and tissue‐fraction corrected metabolic distributions in human central brain structures using 2d (1)h magnetic resonance spectroscopic imaging at 7 t
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749561/
https://www.ncbi.nlm.nih.gov/pubmed/33216472
http://dx.doi.org/10.1002/brb3.1852
work_keys_str_mv AT bhogalalexa lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT broederstommyaa lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT morsinkhoflisan lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT edensmirte lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT nassirpoursahar lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT changpaul lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT klompdenniswj lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT vinkerschristiaanh lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t
AT wijnenjanniep lipidsuppressedandtissuefractioncorrectedmetabolicdistributionsinhumancentralbrainstructuresusing2d1hmagneticresonancespectroscopicimagingat7t